Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients
PaperCitations, authors & open-access status
PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 42 citations, 2022 year and gold oa status.
42
Citations
2022
Year
gold
OA Status